You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0329 A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat when Treating Hyperuricemia Associated with Gout

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
FRI0329 A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat when Treating Hyperuricemia Associated with Gout

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20153400
Jul 20152500
Aug 20152902
Sep 20153601
Oct 20151805
Nov 20155905
Dec 20153205
Jan 20165003
Feb 20163508
Mar 20163002
Apr 20164801
May 20168204
Jun 20162300
Jul 20161500
Aug 20162203
Sep 20163702
Oct 20162703
Nov 20161100
Dec 20161900
Jan 20172200
Feb 20173001
Mar 20172300
Apr 20172201
May 20171101
Jun 20171500
Jul 20174802
Aug 20174000
Sep 20172000
Oct 20171600
Nov 20171200
Dec 20172600
Jan 20182400
Feb 20181801
Mar 20181600
Apr 20182400
May 20184001
Jun 20181200
Jul 20183000
Aug 20182600
Sep 20183000
Oct 20181400
Nov 20181400
Dec 20181200
Jan 20191701
Feb 20192900
Mar 20192301
Apr 20191000
May 20191500
Jun 20192002
Jul 20191402
Aug 2019300
Oct 20192100
Nov 20198000
Dec 20191401
Jan 20201100
Feb 2020400
Mar 20201300
Apr 2020201
May 2020200
Jun 20201000
Jul 2020600
Aug 20201400
Sep 20203600
Oct 20202300
Nov 20202600
Dec 20201400
Jan 20211700
Feb 20212100
Mar 20213401
Apr 20211600
May 20211100
Jun 2021602
Jul 2021500
Aug 2021300
Sep 2021700
Oct 2021700
Nov 20211000
Dec 20211500
Jan 20221100
Feb 2022200
Mar 2022400
Apr 20221000
May 20221000
Jun 2022300
Jul 20221600
Aug 20221100
Sep 2022600
Oct 20222200
Nov 20222900
Dec 2022900
Jan 2023400
Feb 20231200
Mar 2023400
Apr 2023200
May 2023600
Jul 2023300
Aug 2023500
Sep 2023800
Oct 2023100
Nov 2023200
Dec 20231500
Jan 2024300
Feb 2024900
Mar 20241000
Total1953062